Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)
BET inhibitors (BETi) including OTX015 (MK-8628) and JQ1 demonstrated antileukemic activity including <i>NPM1c</i> AML cells. Nevertheless, the biological consequences of BETi in <i>NPM1c</i> AML were not fully investigated. Even if of better prognosis AML patients with <i...
Guardado en:
Autores principales: | Hanane Djamai, Jeannig Berrou, Mélanie Dupont, Marie-Magdelaine Coudé, Marc Delord, Emmanuelle Clappier, Alice Marceau-Renaut, Anna Kaci, Emmanuel Raffoux, Raphaël Itzykson, Caroline Berthier, Hsin-Chieh Wu, Rita Hleihel, Ali Bazarbachi, Hugues de Thé, André Baruchel, Claude Gardin, Hervé Dombret, Thorsten Braun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/52d5e94b12ce456bbf18b65e4c1fbdfe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors
por: Lenka Besse, et al.
Publicado: (2021) -
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
por: Sibylle Cocciardi, et al.
Publicado: (2019) -
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
por: Arvind Singh Mer, et al.
Publicado: (2021) -
Nucleolar protein NPM1 is essential for circovirus replication by binding to viral capsid
por: Jianwei Zhou, et al.
Publicado: (2020) -
NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma
por: Yangfan Zhou, et al.
Publicado: (2021)